Angela Benton went from teen motherhood to building NewME, Streamlytics, and Heirloom, reshaping access to capital, data, and ...

C-store products with catchy names continue on menus, while there appears to be no end in sight for foodservice labor woes ...

“We are grateful to the family who made it possible to provide expanded access to zervimesine for people who were in the Phase 2 DLB study,” stated Lisa Ricciardi, president and CEO of Cognition ...

The Trump administration’s proposal would apply to visitors from countries included in the Visa Waiver Program ...

The U.S. may soon require foreign tourists to hand over five years of social media history in order to enter the country. U.S ...

Company now authorized to assign and publish CVE IDs, enhancing transparency, accuracy, and efficiency in vulnerability disclosure ...

In mCRPC patients with androgen receptor (AR) mutations, treatment with MRT-2359 in combination with enzalutamide led to a 100% PSA response rate (4 of 4 patients) and a 100% disease control rate, ...

DAVE LIEBER is “The Watchdog” investigative columnist for The Dallas Morning News who fights for his readers and exposes bad ...

Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will ...

With Arc Intelligence, teams can automate previously manual steps, reduce effort, and access actionable, context-rich guidance. Users can streamline repetitive work such as creating records during ...

In mCRPC patients with androgen receptor (AR) mutations, treatment with MRT-2359 in combination with enzalutamide led to a 100% PSA response rate ...

Emory University physician-sponsored clinical trial conducted at the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of ...